Cardio-Respiratory Health and Indoor Pollution

NCT ID: NCT01329159

Last Updated: 2011-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-04-30

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess in the sample of population resident in the KHUMBU valley (NEPAL):

1. the respiratory function decline by means of spirometry and the respiratory health by means of questionnaire and six-minute walking distance
2. the presence of markers of early atherosclerosis with ultrasound and to estimate the value of systolic pulmonary pressure in comparison with not exposed subjects.

The investigators hypothesize that the chronic exposure to indoor pollution

1. can accelerate the physiological respiratory function decline, usually around 15-20mL/year in healthy subjects
2. induce cardiovascular impairment

The population of high altitude villages is a unique sample to study the effect of the only indoor pollution. In fact, the absence of traffic, due to the lack of roads, and the very low level of smoking habits allow to have no other confounding factors
3. to study and analyze how the architectural features of the buildings of the village (distribution of domestic locals, natural or non natural ventilation systems, domestic activities, materials used, etc.) affect the indoor pollution from carbon monoxide, which necessarily is developed indoor during the daily life activities.

What the project prospects is to gather information focused on the scale of the building, independently from the typology, to study a model that will help to describe which aspects are most important to what concern the genesis of the pollution of the indoor air.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease Cardiovascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* residents in the villages of the valley

Exclusion Criteria

* under the age of 14
Minimum Eligible Age

14 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

OTHER_GOV

Sponsor Role collaborator

Università degli Studi di Ferrara

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Ferrara

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Annalisa Cogo, MD

Role: STUDY_DIRECTOR

University of Ferrara, Italy

Lorenza Pratali, MD

Role: PRINCIPAL_INVESTIGATOR

Institute of Clinical Physiology National Council of Research, Pisa, Italy

Luca Pomidori, PhD

Role: PRINCIPAL_INVESTIGATOR

Università degli Studi di Ferrara

Sanjay Nath Khanal, MD

Role: PRINCIPAL_INVESTIGATOR

Kathmandu University

Enrico Duo

Role: PRINCIPAL_INVESTIGATOR

Università degli Studi di Ferrara

Maria Rosa Bruno, MD

Role: PRINCIPAL_INVESTIGATOR

Institute of Clinical Physiology National Council of Research, Pisa, Italy

Chan Bahadur Thapa, MD

Role: PRINCIPAL_INVESTIGATOR

Tribhuvan University Institute of Medicine (Nepal)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Clinical and Experimental Medicine- section of Respiratory Disease-University of Ferrara

Ferrara, Ferrara, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Annalisa Cogo, MD

Role: CONTACT

+390532210420

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Annalisa Cogo, MD

Role: primary

+390532210420

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HA indoor/pollution

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.